CSF2 and autoimmune pulmonary alveolar proteinosis: The presence of anti GM-CSF antibodies in patients with aPAP leads to a reduction in the ability of alveolar macrophages to clear debris and pathogens, maintain surfactant homeostasis, and limit inflammation in the alveolar environment [19].